Genocea Biosciences (GNCA) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- CoreWeave stock drops on dilution fears and debt concerns
Genocea Biosciences (GNCA) PT Lowered to $2 at Cowen
February 15, 2018 3:00 PM ESTCowen lowered its price target on Genocea Biosciences (NASDAQ: GNCA) to $2.00 (from $5.00) while maintaining a Outperform rating.
Analyst Phil Nadeau commented, "Genocea reported Q4 financials including a net loss of $11MM and a pro-forma cash balance of $64MM. Meanwhile, lead... More



